3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
4
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
129
Breast Neoplasms
112
Neoplasms
96
Neoplasm Metastasis
79
Melanoma
73
Leukemia, Myeloid, Acute
69
Colorectal Neoplasms
68
Prostatic Neoplasms
60
Multiple Myeloma
52
Lung Neoplasms
52
Ovarian Neoplasms
51
Squamous Cell Carcinoma of Head and Neck
47
Triple Negative Breast Neoplasms
43
Recurrence
41
Carcinoma, Renal Cell
40
Carcinoma, Hepatocellular
39
Pancreatic Neoplasms
36
Myelodysplastic Syndromes
36
Glioblastoma
35
Brain Neoplasms
34
Lymphoma
31
Stomach Neoplasms
30
Lymphoma, Non-Hodgkin
30
Leukemia
29
Lymphoma, Large B-Cell, Diffuse
28
Head and Neck Neoplasms
28
Endometrial Neoplasms
28
Uterine Cervical Neoplasms
26
Cholangiocarcinoma
26
Urinary Bladder Neoplasms
24
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms, Nerve Tissue
×
1 year
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts